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Kathryn B. Garber1,*One of These Things Is Not Like the Other
California screens newborns for nonsickling hemoglobin-
opathies because a significant fraction of its population is
drawn from parts of the world where these disorders are
common, such as Asia. One such disorder is hemoglobin
H (HbH), which is a type of a-thalassemia that typically
results from deletion of three of the four copies of the
a-globin gene. Another a-thalassemia that is lumped in
with HbH is hemoglobin constant spring (HCS). People
with HCS have one allele on which both copies of a-globin
are deleted and a particular destabilizingmutation in one of
the two copies of a-globin on the other allele. Lal et al.
recently published a natural-history study of patients with
HbH and HCS, all of whom were followed under uniform
management guidelines. This allowed them to compare
thedisease courseofHbHto thatofHCSand todemonstrate
that HCS is actually a unique and more severe disease.
Unlike patients with HbH, children and even infants with
HCS were at risk of life-threatening anemia that was often
precipitated by febrile illness. This meant that 80% of kids
withHCS required a blood transfusion by age 20, compared
to 2.8% of those with HbH. The HCS group also had signif-
icant growth delay. HCS needs to be considered a distinct
form of a-thalassemia, andmanagement guidelines should
be developed specifically for this disorder.
Lal et al. NEJM 364, 710–718.
IL-17-Specific Immunodeficiency
When I think of genetic immunodeficiencies, I have an
image of the ‘‘Bubble Boy’’ in my head. Some immunode-
ficiencies are much more specific, leading to a very
restricted susceptibility to infections. One such example
is chronic mucocutaneous candidiasis disease, which is
a condition characterized by recurrent or persistent infec-
tions by Candida albicans, a benign, commensal organism
in most people. In the mouth, this infection is called
thrush. Unraveling the genetic underpinnings of this
condition, Puel et al. leave us with a greater understanding
of the immunological control of this organism. In one
affected family, they found a mutation in an IL-17 receptor
gene, and in another family they found a dominant-nega-
tive mutation in the cytokine IL-17F. Both mutations were
shown to alter cytokine signaling. Thus, IL-17 cytokines
are critical for protective immunity against C. albicans
and S. aureus, which can also cause recurrent infections
in people with this deficiency. Relevant to this point is1Department of Human Genetics, Emory University School of Medicine, Atlan
*Correspondence: kgarber@genetics.emory.edu
DOI 10.1016/j.ajhg.2011.03.017. 2011 by The American Society of Human
The Amthe fact that clinical trials are underway to test the effects
of blocking IL-17A as a treatment for psoriasis, rheumatoid
arthritis, and noninfectious uveitis. These patients will
need to be monitored for the infections that are the hall-
mark of IL-17 signaling deficiencies.
Puel et al. Science Express. Published online February 24,
2011. 10.1126/science.1200439
Toxic RNA Underlies Advanced Age-Related Macular
Degeneration
Age-related macular degeneration (AMD) is a leading cause
of vision loss in the industrialized world, and there is no
effective therapy for the common forms of this disease.
On the severe end of the spectrum of AMD is geographic
atrophy, which occurs when the retinal pigment epithe-
lium (RPE) atrophies. Recent work by Kaneko et al.
implicates RNA transcribed from Alu elements in the path-
ogenesis of geographic atrophy. This work began when the
authors realized that levels of the RNase DICER1 were
reduced in RPE affected by geographic atrophy and that
artificially reducing DICER expression in the RPE led to
its degeneration. DICER1 is most famous for its role in
the production of microRNAs, but this function turns out
not to be central to AMD. Instead, reduction in DICER1
expression leads to the accumulation of long, double-
stranded RNAs that correspond to Alu transcripts. The
Alu RNAs themselves are cytotoxic, probably the effect of
triggering an apoptotic mechanism. Thus, DICER1 seems
to perform a cell-protective function by degrading toxic
RNAs. AMD is one of the most well understood complex
genetic traits and was the subject of one of the very first
successful genome-wide association studies. Genes encod-
ing components of the complement pathway were the first
pulled out by these studies, and they confer substantial risk
of AMD. I, for one, am looking forward to seeing how these
two chapters of the AMD story tie together.
Kaneko et al. Nature 471, 325–330.
Saying No to Amnio?
We are closer than we have ever been to the incorporation
of noninvasive prenatal diagnosis of trisomy 21 into clin-
ical practice. Chiu et al. recently published the first large-
scale study that demonstrates the feasibility of detecting
trisomy 21 via sequence of free DNA in maternal plasma.
Compared to current maternal-serum-screening protocols,
the sequence-based approach was better able to detectta, GA 30322, USA
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trisomy 21, at least in their study sample, which was
composed of a group of women that had already been
identified as having high risk of trisomy 21. Whether
that holds true in a fully prospective study in a more
general population remains to be seen. Beyond that, the
question could soon become not whether to incorporate
this approach of fetal-risk assessment into the clinic but
how to do so: Will it replace the serum screen? Will it be
used to avoid invasive diagnostic procedures? In a recent
Community Corner in Nature Medicine, four experts
make their views on this topic known.
Chiu et al. British Medical Journal 342, c7401; Nature Medi-
cine 17, 250–251.
Long-Term Outcomes for Xeroderma Pigmentosum
Hypersensitivity to sun exposure is a classic feature of xero-
derma pigmentosum (XP). You might think that everyone
with this disorder gets extreme sunburns as a result of
minimal sun exposure, but in fact, not all do. Those who
are hypersensitive to sun are actually at lower risk of skin
cancer than those who don’t sunburn. Teasing out this400 The American Journal of Human Genetics 88, 399–400, April 8, 2variability in XP is more feasible as the result of the recent
paper by Bradford et al., who report the natural history of
XP in patients referred to the NIH since 1971. This repre-
sents a group of patients dating all the way back to the
time just after DNA-repair defects were found to be the
underlying cause of XP. There are seven complementation
groups for XP, plus a variant group. This work clarifies
some differences between the complementation groups
in terms of the age at which skin cancer occurs, the median
age at death, and the likelihood of neurological degenera-
tion, which occurs in about a quarter of XP patients but
is largely restricted to two of the complementation groups.
It also indicates that in the XP group overall, nonmela-
noma skin cancers tend to be diagnosed earlier than mela-
nomas, which is opposite to what is seen in the general
population. Because this is a rare disorder, it has been diffi-
cult to study subgroups of XP. This long-term study of
a significant sample of patients has begun to make this
possible and is important for our greater understanding
of this rare disorder.
Bradford et al. Journal of Medical Genetics 48, 168–176.This Month in Our Sister JournalsNetworking
When you’re working with a complex biological system,
you must focus your hypotheses and limit yourself as to
the number of measured endpoints. If you want to match
genetic variation with phenotypic variation and establish
causation, these constraints can limit your progress. Hage-
man et al. have come up with an in silico approach to
selection of hypotheses for studying complex genetic
interactions. They developed a Bayesian model to infer
networks of causation and used this to sort through kidney
expression quantitative trait loci (eQTL) data derived from
an interstrain mouse cross. Their analysis of the renin-
angiotensin system uncovers previously unrecognized
regulatory links in the pathway. They believe that this
will allow them to better predict the effects of interven-
tions in the pathway and to generate specific hypotheses
for testing.
Hageman et al. Genetics. Published online January 17, 2011.
10.1534/genetics.110.123273.
You Want a Piece of Me?
Parents in Texas recently sued the state because they
were angry that leftover newborn bloodspots were stored
and could be used for research without notification orinformed consent of parents. Parents in other states have
filed similar lawsuits. News stories by the Associated Press
quoted parents as saying that they would have given
consent for use of the bloodspots had they simply been
asked. On the other hand, according to a recent survey
by Richer et al., a significant percentage of medical
geneticists worry that newborn-screening rates will fall if
newborn-screening literature includes a statement that
a child’s blood will be stored and could be used for DNA
research. Despite this worry, themajority of those surveyed
favored a model of public notification with an opt-out
option for parents who do not wish their child’s newborn
blood sample to be stored. Leftover bloodspots can be
a treasure trove to genetic researchers, providing them
with an unbiased sample of a general population. This is
important, for example, for the development of novel
newborn-screening strategies. Keeping in mind that focus
must be maintained on newborn screening itself, further
discussions involving parents, physicians, and public
health officials are needed in order to develop more
discrete policies on the storage and use of these leftover
bloodspots.
Richer et al. Genetics in Medicine. Published online October
1, 2010. 10.1097/GIM0b013e3181f69da0.011
